In accordance with the most recent industry analysis from Future Market Insights, the global protein diagnostics market was valued at approximately $4.7 billion in 2022. It is forecasted to experience a robust compound annual growth rate (CAGR) of nearly 5.4% over the projected period, leading to an estimated market.
"The major players operating in this market are Asahi Kasei Corporation (Japan), Beijing Strong Biotechnologies, Inc. (China), Diazyme Laboratories, Inc. (US), DxGen Corp. (South Korea), Weldon Biotech (India), Hzymes
As per Future Market Insights’ latest industry analysis, the valuation for the global Protein Diagnostics Market was around US$ 4.7 Billion in 2022 and is projected to exhibit a CAGR growth of close to 5.4% over the forecast period, with an estimated valuation of US$ 8.3 Billion in 2033.According to the European Uni.